Several distinctive neurologic disorders of unknown etiology occur as "paraneoplastic syndromes" or "remote effects" of systemic cancer (1) . The syndrome of paraneoplastic cerebellar degeneration (PCD) is among the most common of these disorders and generally occurs in patients with neoplasms of the lung (especially small cell carcinoma), breast, ovary, or with Hodgkin disease (1, 2) . Neuropathologic features of PCD include extensive loss of Purkinje cells, degenerative changes in the remaining Purkinje cells, variable loss of granule and basket neurons, proliferation of Bergmann glial cells, and a variable degree of perivascular and meningeal infiltration by lymphocytes and other mononuclear cells. The presence of anti-Purkinje cell antibodies in some PCD patients suggests an autoimmune etiology (3) (4) (5) (6) . Immunofluorescent staining of Purkinje cell cytoplasm has been reported in cases of PCD associated with Hodgkin disease (3), small cell lung cancer (4) , breast cancer (5) , and ovarian cancer (5, 6) . Several investigators have attempted to characterize the putative neuronal antigens reacting with anti-Purkinje cell antibodies. Immunoblots with sera from PCD patients have identified several brain proteins of various molecular weights (7) (8) (9) (10) , but the identity of these "target" proteins and their role in the pathogenesis of PCD remain unknown. Direct efforts at purifying the target proteins have been hampered by their restricted cellular distribution and relatively low abundance. We have used the autoantibodies from a patient with PCD to identify and clone a gene from a human cerebellum cDNA library. The gene is expressed predominantly in neuroectodermal tissues and encodes a protein with a distinctive tandemly repeating structure.
MATERIALS AND METHODS
Human and Mouse Tissue. Normal human cerebellar cortex, cerebral cortex, and other tissues were obtained at autopsy. BALB/c mice were from our breeding colony. Tumor cell lines were from the Sloan-Kettering Institute collection.
DNA and RNA Preparations. High molecular weight cellular DNA and total cellular RNA were prepared as described (11) . Poly(A)+ RNA was isolated by oligo(dT)-cellulose column chromatography (12) .
Construction of Xgtll cDNA Library. A Xgtll cDNA library was constructed from human cerebellar poly(A)+ RNA according to Huynh et al. (13) . cDNA species >300 base pairs (bp) were size-selected by 5% polyacrylamide gel electrophoresis and ligated to EcoRI-digested dephosphorylated Xgtll arms in a molar ratio of 2:1 (13, 14) . The ligated DNA was packaged using a high-efficiency in vitro packaging extract (Vector Cloning Systems, San Diego, CA). Approximately 2.3 x 105 plaques were obtained, with 70% being recombinants. An amplified stock of the library was prepared in Escherichia coli Y1088 (12) and used for antibody screening.
Antibody Screening of Xgtll Library. Serum used for screening was obtained from a patient with adenocarcinoma of unknown origin, PCD, and high-titer anti-Purkinje cell antibodies. IgG was isolated from the serum by ammonium sulfate precipitation and DEAE-Sephadex chromatography (15) . Recombinant phage were screened at a density of 8000 plaque-forming units per 85-mm plate of E. coli Y1090. The plates were incubated at 42°C for 4 hr, overlaid with nitrocellulose filters (Millipore) saturated with isopropyl P-Dthiogalactopyranoside (IPTG), and incubated 3 hr at 37°C. Filters were washed in Tris HCl/NaCl/Tween 20 and incubated at 4°C overnight with the primary antibody solution containing 2% bovine serum albumin and preabsorbed with a lysate ofE. coli. Incubation at room temperature for 4 hr with horseradish peroxidase-conjugated goat anti-human IgG (Bio-Rad) was followed by staining with chloronaphthol (Bio-Rad). Clones yielding positive signals were purified by several rounds of antibody screening until 100% of the plaques gave positive signals.
Preparation and Immunoblotting of Agtll Fusion Proteins. Lysogens of recombinant phage were prepared in E. coli Y1089 (13) at a multiplicity of infection of 5. Cultures were grown at 32°C to an OD550 of 0.5, followed by induction of lytic growth at 44°C for 30 min, addition of IPTG to a concentration of 10 mM, and incubation at 37°C for 2 hr. Bacterial pellets were lysed in cold Tris HCl/EDTA/lysozyme buffer (16) , sonicated, and centrifuged. The supernatants were diluted in NaDodSO4/polyacrylamide gel sample buffer containing 5% 2-mercaptoethanol, electrophoresed in 7% NaDodSO4/polyacrylamide gel (17) , and electrophoretically transferred to nitrocellulose (18) . Blots were analyzed with the patient's serum as described above for antibody screening. Plaque Hybridization. Nitrocellulose filters were overlaid on 85-mm phage plates for 4 min, washed at room temperature for 4 min each in 1 M NaCl/0.5 M NaOH, 2 M NaCl/1 M TrisHCl, pH 6.8, and 2x SSC (lx SSC = 0.15 M NaCl/0.015 M sodium citrate), then vacuum-dried at 80'C for 2 hr. Filters were hybridized and washed as described for Southern blot analysis (see below), except that dextran sulfate was omitted from the hybridization solution.
DNA Sequencing and Analysis. cDNA clones were subcloned into M13mpl8 and M13mpl9, sequenced by the dideoxy chain-termination method (19) , and analyzed with computer programs from BIONET.
RNA Blot and Cytoplasmic Dot Blot. RNA blot and RNA dot blot analyses were done as described (20) alanine) and on the carboxyl side by an aliphatic residue, usually followed by aspartic acid. A nonrepetitive segment of 17 amino acids is found at the carboxyl terminus of the peptide due to a single nucleotide insertion that disrupts the reading frame.
A hydropathy profile (23) of the predicted amino acid sequence (Fig. 5 ) reveals an initial hydrophobic segment, followed by cycles of alternating very hydrophilic and slightly hydrophobic regions with a periodicity of =40 amino acid residues, and ending with a slightly hydrophilic nonrepetitive segment. The predicted secondary structure of the sequence according to the method of Chou and Fasman (24) is an a-helix, with a 8-sheet conformation extending along 30 amino acids at the carboxyl end.
In comparison to the pCDR13 sequence, pCDR6 and pCDR8 both lack a 204-bp segment that includes the translational termination codon of pCDR13. This indicates a possible alternative splicing of mRNA, as supported by the presence of multiple mRNA species in RNA blots (see below). Because of the deletion, the predicted amino acid sequences of pCDR6 and pCDR8 are slightly different from Southern Blot Analysis of the CDR Gene in Human and Mouse. Southern blot analysis showed hybridization of the 1.2-kilobase (kb) pCDR13 probe to single fragments in digests of human genomic DNA by BamHI, EcoRI, HindIII, Pst I, and Pvu II (Fig. 6 ). These findings are consistent with single-copy representation of the CDR gene. The observation that different restriction enzymes generated single fragments also suggests that the entire pCDR13 cDNA clone was derived from one exon or from exons lacking restriction sites in the intervening sequences. Southern analysis of restriction digests of mouse genomic DNA also showed strong hybrid- Hydropathy values for a span of seven amino acid residues were averaged, assigned to the middle residue of the span, and plotted (y axis) according to the position of the middle residue along the sequences (x axis). ization signals (Fig. 6) , indicating that the CDR gene is highly conserved between human and mouse.
Analysis of CDR Transcripts in Normal and Tumor Cells. Fig. 7 shows the RNA dot blot analysis of CDR transcripts in human and mouse tissue. CDR mRNA was detected in abundant amounts in human cerebellar cortex and cerebral hemisphere cortex, but it was only barely detectable in lung, kidney, and heart muscle. At least 500-fold differences were estimated between the levels of CDR messages in brain and non-neural tissues. In mouse tissue, the mRNA was estimated to be 5-10 times more abundant in cerebellum than in cerebrum and was undetectable in lung, heart, kidney, liver, and thymus.
Human tumor cell lines were also tested by cytoplasmic dot hybridization with the pCDR13 probe ( Table 1) . The message was present in all 10 neuroblastoma lines tested, as well as in the majority of renal cell carcinoma lines and a proportion of astrocytoma, melanoma, and lung carcinoma lines. The degree of expression by positive cell lines varied widely for a given tumor type, with no obvious correlation with morphological characteristics. The strongest expression was observed in several of the neuroblastoma and renal carcinoma lines, nearly approaching the abundance of the CDR message in normal brain tissue. The CDR message was (Fig. 8 ). This mRNA heterogeneity may be due to alternative splicing, as suggested by structural studies of cDNA clones pCDR6 and pCDR8 (Fig. 3) . RNA blot analysis of rabbit and mouse brain confirmed the greater expression of the CDR gene in cerebellum than in cerebrum (Fig. 8 ).
Rabbit CDR messages were similar in size to the human transcripts, except for the absence of the 1.3-kb species. In contrast, the blot of mouse brain RNA showed only a single 3.5-kb message.
DISCUSSION
To identify the molecular targets for anti-brain antibodies in PCD, we have used the serum from a patient with PCD to isolate a cDNA clone from a human cerebellum Xgtll expression library. The nucleotide sequence of the CDR cDNA contains a pattern of tandem repeats with a structure that is unlike any known eukaryotic gene. In addition, the 14 ki tII pattern of expression of the CDR gene does not resemble any previously described neuroectodermal gene. CDR gene transcripts are found much more abundantly in normal adult brain, especially cerebellum, than in non-neural tissues. The low level of CDR message in human lung, kidney, and heart muscle could be due to expression in the small subpopulation of cells of neuroectodermal origin in these tissues. Tandemly repeated sequences are known to characterize a number of surface proteins of malarial parasites. For example, the circumsporozoite protein of Plasmodium falciparum consists almost entirely of tandem repeats of 4 amino acids (25) , while that of Plasmodium knowlesi contains 12 repeats of a 12-amino acid unit (26) . These Plasmodium circumsporozoite proteins show a high degree of antigenicity and are able to serve as the targets for neutralizing antibodies. Most eukaryotic proteins with known tandem repeats are structural proteins, such as the intermediate filaments (27) , nuclear lamins (28) , myosin (29) , and a-tropomyosin (30) . These proteins form coiled coils and share a common structural pattern of tandemly repeating units of 7 amino acids, with hydrophobic residues occupying the first and fourth positions. However, there are otherwise no restrictions on the amino acids in the repeating units of these proteins, in contrast to the CDR molecule. Two structural proteins show certain similarities to the CDR gene product. Involucrin, a keratinocyte envelope component, contains a central segment of 39 repeats of 10 amino acids and appears to be a substrate for cross-linking by transglutaminase (31) . The PrP prion protein, thought to polymerize into fibrils, contains well-conserved tandem repeats of 8 amino acids extending over 13% of its sequence (32, 33) . To our knowledge, the only nonstructural eukaryotic protein with tandem repeats is RNA polymerase II, with a highly conserved unit of 7 amino acids repeated 26 times in the COOH-terminal sequence (34, 35) . Knowledge of the tandem repeat composition of the CDR protein itself, therefore, does not allow insight into possible cellular functions.
Is the protein product of the CDR gene an important target in the pathogenesis of PCD? The fact that this molecule is recognized by the PCD patient's serum and that transcripts for it are expressed predominantly in neural tissues (especially cerebellum) is consistent with a significant disease association. The absence of the CDR mRNA in breast and ovarian cancer cell lines and its presence in primary tumors from two PCD patients (one breast adenocarcinoma and one ovarian carcinoma; unpublished data) add to a possible association. It is also likely that a molecule with such tandemly repeated structures might be highly immunogenic and thus the target of an autoimmune response. However, recognition of this molecule by the immune system may be secondary to cell destruction in PCD and not causally related to the pathogenesis of PCD. The observation that the CDR gene is highly conserved in mouse and rabbit may provide valuable animal models for further studies of this molecule.
